+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a cholesterol-synthesis inhibitor (triparanol)



Evaluation of a cholesterol-synthesis inhibitor (triparanol)



Annals of Internal Medicine 53: 462-467




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048993276

Download citation: RISBibTeXText

PMID: 13691207


Related references

Cholesterol biosynthesis in skin: The effects of a cholesterol inhibitor, triparanol. Canadian Med Assoc Jour 88(5): 259-260, 1963

Clinical trial of an inhibitor of cholesterol hiosynthesis, triparanol or MER-29. Revue de l'Atherosclerose 3(Suppl 1): 34-43, 1961

Influence of An Inhibitor of Cholesterol Biosynthesis (Triparanol) on the Concentration of Sterols in Rat Tissues. Journal of Atherosclerosis Research 4: 161-169, 1964

The effects of an inhibitor of cholesterol biosynthesis triparanol (MER-29), in subjects with and without coronary artery disease. Bmq; the Boston Medical Quarterly 10(2): 37-44, 1959

Cholesterol metabolism as modified by nicotinic acid and its analogues, triparanol, and dietary fat: Effects on cholesterol synthesis, bile acid formation, and atherosclerosis. Diss Abstr 25(7): 4187-4188, 1965

Probucol and the cholesterol synthesis inhibitors simvastatin and triparanol regulate I ks channel function differently. Human and Experimental Toxicology 32(10): 1028-1037, 2013

Inhibition of cholesterol synthesis and cell growth by 24(R,S),25-iminolanosterol and triparanol in cultured rat hepatoma cells. Journal of Biological Chemistry 264(11): 6230-6238, 1989

Effects of cholesterol synthesis inhibitors on the nervous system a inst light microscopy and inst electron microscopic study triparanol metab 20 25 di aza cholesterol metab clofbirate metab rat. Laboratory Investigation 19(5): 487-493, 1968

Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin. Minerva Medica 83(11): 677-693, 1992

Effect of MER-29 (triparanol) on serum cholesterol, cholesterol esters and liver enzymes. Progress in Cardiovascular Diseases 2: 624-630, 1960

The clinical evaluation of the hypocholesterolemic effects of an inhibitor of cholesterol synthesis: mevalonic acid. La Clinica Terapeutica 141(7): 47-50, 1992

Deficient cholesterol synthesis is inherited in sitosterolemia sitosterol is not a feedback inhibitor of cholesterol synthesis. Gastroenterology 102(4 Part 2): A887, 1992

Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor. Official Gazette of the United States Patent & Trademark Office Patents 1214(3): 2941-2942, 1998

Changes in cholesterol, cholesterol esters, phospholipids and total amount of plasma lipids, in the lipoprotein ratio, and in the electrophoretic pattern of serum proteins in aged patients following triparanol treatment. Giorn Gerontol 10(1): 63-72, 1962

Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(11): 523-527, 1992